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AbstrACt
Objectives Gastrostomy decision making is a 
complicated, multifaceted process for people with motor 
neuron disease (MND). This study explored demographic 
and disease- related factors that may impact on 
gastrostomy uptake; and reasons why people with MND 
accepted or declined gastrostomy, with a focus on how 
perceptions of swallowing and nutrition may influence 
decision making.
Design Prospective, cross sectional, mixed methods.
setting An Australian multidisciplinary, specialty MND 
Service.
Participants 33 patients were recommended gastrostomy 
by the treating medical specialist. 16 of 33 were invited 
to participate in the prospective decision making study; of 
whom 10 provided informed consent.
Primary and secondary outcome 
measures Demographic and disease- related factors 
contributing to uptake are described. A stepped approach 
was applied to gain a comprehensive understanding of 
why people with MND accept or decline gastrostomy. 
Instruments included standardised assessments, nutrition 
survey and semistructured interview. Data were collected 
at three separate appointments, spanning a 3- week 
period.
results Gastrostomy uptake was 73% following medical 
specialist recommendation. Participants took days, weeks 
or months to consider their preferences, with lengthy 
hospital waiting times for the procedure. Gender, site of 
onset and rate of disease progression were observed to 
contribute to uptake. Age and symptom duration did not. 
Integration of quantitative and qualitative data suggests 
that patient perceptions of swallowing and nutrition 
contribute to gastrostomy acceptance; however, the 
decision making process is heterogeneous and these 
factors may not be the sole or primary reasons for 
acceptance. Other reported factors included: reducing 
carer burden, improving quality of life, increasing 
independence, continuing participation in social outings 
and gaining control.
Conclusions Future research may give greater insight 
into how healthcare organisations can better facilitate 
gastrostomy decision making, to meet the needs of people 
living with MND. Larger, prospective, multisite studies may 
build on these findings to better inform clinical guidelines 
and minimise the impacts of delayed gastrostomy 
insertion.
IntrODuCtIOn
Motor neuron disease (MND) is the name 
given to a group of progressive neurological 
diseases whereby motor neurones degenerate 
and die. Voluntary control of muscles is lost, 
causing difficulties with mobility, speech, 
swallowing and breathing. Average survival 
from symptom onset ranges from 20 to 48 
months.1 2 People living with MND are faced 
with many challenging decisions during the 
course of their illness,3–5 including whether 
to undergo gastrostomy or not.
Gastrostomy may be suggested for long- 
term nutritional support. It offers a useful 
method for administering medication, food 
and fluid, to stabilise weight loss and poten-
tially prolong survival.6–9 Reported gastros-
tomy uptake rates vary considerably in MND, 
ranging from 14% to 60% internationally, 
with a trend for increased usage rates over 
the past few decades.10 A variety of factors 
have been found to contribute to gastrostomy 
uptake, including: employment status, IQ, 
education, executive function, perceptions 
and attitudes11; spirituality or religion11 12; 
early positive views towards gastrostomy13; ALS 
Functional Rating Scale- Revised (ALSFRS- R) 
swallowing score, forced vital capacity (FVC) 
and use of non- invasive ventilation (NIV)14; 
pleasure associated with oral intake or ability 
strengths and limitations of this study
 ► Few studies have focused solely on gastrostomy de-
cision making in motor neuron disease.
 ► None have used a mixed- methods approach, allow-
ing both patient perspectives and clinician- reported
measures to be captured, for comprehensive under-
standing of this complex topic.
 ► Integration of quantitative and qualitative data was
achieved through repeated iteration process.
 ► The small sample size in a single clinic setting may
limit generalisability of the findings; however, this
provides foundation knowledge for future studies.
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Figure 1 Participant recruitment.
to feed self15 and the use of nutritional support teams 
during initial gastrostomy discussion.16
Practice guidelines offer some support for clinicians 
regarding the timing of insertion7 8 17; however, most 
healthcare professionals (HCPs) find the issue of gastros-
tomy timing to be extremely challenging.18 Guidelines 
recommend that gastrostomy should be considered soon 
after symptom onset7 and offered at least annually8; swal-
lowing and nutrition risk should be screened 3 monthly,8 
with gastrostomy indicated for those with symptomatic 
dysphagia and associated weight loss.7 17 Respiratory func-
tion should also be considered, with possibly less surgical 
risks if gastrostomy is placed before FVC falls below 
50%.8 17 19 It has been suggested that further research is 
required to determine what degree of swallowing impair-
ment, nutritional compromise and respiratory impair-
ment indicates the need for gastrostomy.6 7
Before recommending gastrostomy, clinicians should 
be aware of each person’s health status, prognosis, 
potential ethical issues, the expected effect on quality of 
life (ie, QoL) and the person’s preferences.9 Proactive 
gastrostomy discussions are beneficial for both patients 
and families,20 as delayed insertion may lead to a higher 
rate of unplanned insertions,21 resulting in: a higher 
30- day mortality rate21; increased length of hospital stay;
fewer home discharges and increased healthcare costs.22
However, there is often disparity between patients’ deci-
sions and practice guidelines, even when conditions for
decision making are optimal.23 Barriers to well- timed
gastrostomy decisions include: patients perceiving a lack
of clear advice from HCP’s around the ‘right time’ for
insertion24; patient reluctance to plan for the future4 25
and varying personality philosophies.4 Stavroulakis et al26
also reported the following factors can influence the
decision of gastrostomy insertion, and thus delay the
procedure: a reluctance to give up oral feeding, a lack
of understanding of the potential benefits and negative 
perceptions of gastrostomy tubes.
This study aimed to explore: (1) demographic and 
disease- related factors that may impact on gastrostomy 
uptake and (2) the reasons why people with MND accept 
or decline gastrostomy, with specific focus on how percep-
tions of swallowing and nutrition may influence patients’ 
decision making.
MethODs
Participants and setting
Participants were recruited from a specialty MND Service 
in New South Wales (NSW), Australia, between May 2016 
and February 2018. Participants attended 3- monthly, 
multidisciplinary, MND clinic reviews within a subacute 
hospital setting. Additional outpatient appointments, 
home visits and/or inpatient admissions (Rehabilitation 
or Palliative Care) were provided on an as- needed basis. 
The team included the following: Service Coordinator, 
Rehabilitation Specialist, Neurologist, Palliative Care 
Nurse, Allied Health, Pastoral Care and a representa-
tive from MND NSW. All respiratory investigations and 
gastrostomy insertions were provided by the Respiratory 
and Gastroenterology departments at the nearest major 
tertiary hospital.
recruitment procedure
Gastrostomy need was identified during routine care, 
following deterioration in the patient’s swallowing, nutri-
tion or breathing. Names of patients, who had been 
recommended gastrostomy during a clinical discussion 
with the treating medical specialist (during the study 
period), were provided to the research team (n=33). 
Although some patients are likely to have had prior 
knowledge of gastrostomy, this was the first occasion that 
gastrostomy referral was recommended by the medical 
specialist. Eligible patients were consecutively invited 
to participate in the decision making study, regardless 
of whether they had made a decision or not, to ensure 
that patients were captured during their decision making 
process (figure 1). Inclusion criteria were: sufficient 
English language skills to allow informed consent and 
optimal participation in data collection activities; ability 
to respond to open- ended questions using speech, writing 
or a communication device; sufficient cognitive ability to 
provide informed consent and participate in a semistruc-
tured interview (determined by a score of ≥25/30 on the 
Mini- ACE)27; and residing within a 1- hour drive from the 
hospital, to allow for data collection at home. Patients 
were not invited to participate in the decision making 
study if the treating team considered gastrostomy to be 
an unsuitable option (eg, those with poor health status or 
limited prognosis).
Design
A cross- sectional mixed- methods design28 was chosen as 
the most appropriate method to achieve the study aims 
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Table 1 Instruments and procedures
Purpose Instrument Validated? Person administering
Cognitive screening prior to enrolment Mini- ACE cognitive screener27 Yes Speech pathologist
Overall function rating Self- Reported ALS Functional Rating 
Scale- Revised (ALSFRS- R)35
Yes Speech pathologist
Clinician assessment of swallowing Mann Assessment of Swallowing Ability 
(MASA)36
Yes Speech pathologist
Clinician rating of oral intake 
consistency
Functional Oral Intake Scale (FOIS)37 Yes Speech pathologist
Participant perception of swallowing Swallowing- Quality of Life Scale (SWAL- 
QoL)38
Yes Speech pathologist
Clinician assessment of nutrition Mini Nutritional Assessment (MNA)39 40 Yes Dietitian
Participant perception of nutrition Perception of Nutrition Survey No Dietitian
Explore participant’s thoughts and 
feelings about gastrostomy
Semistructured interview No Researcher
(unknown to the participant)
of investigating the demographic, disease, swallow and 
nutritional status of participants and their perspectives 
on factors affecting their decision making in relation to 
gastrostomy.29–31 The Creswell et al best practice guide-
lines for mixed- methods research29 and the Sale and 
Brazil32 mixed- methods reporting criteria32 informed 
the design and reporting of this study. Descriptive data 
were used to highlight differences in the demographic 
and disease- related characteristics for gastrostomy uptake 
versus declining gastrostomy.
Data collection
To explore factors impacting on gastrostomy uptake, 
the following demographic and disease- related data 
were obtained from the MND Service database: gender, 
age, site of onset, symptom duration (months), the rate 
of disease progression score (also known as ∆FS)33 34 at 
initial visit to the clinic and the predicted rate of decline 
group34 at initial visit to the clinic. The ∆FS was calculated 
using the following formula33 34:
 ∆FS =
48−(Total ALSFRS−R at initial visit)
Symptom duration at initial visit (months)
The ∆FS score was then used to allocate a predicted rate 
of decline group, including: slow (ie, a score of <0.47), 
steady (ie, a score of 0.47–1.11) or rapid (ie, a score of 
>1.11).34
To capture both patient perceptions and clinician-
reported measures of swallowing and nutrition, vali-
dated tools35–40 and a nutrition survey were administered. 
(table 1). Additionally, a semistructured interview guide 
(online supplementary material) explored the reasons 
why people with MND accept or decline gastrostomy; 
with specific focus on how perceptions of swallowing 
and nutrition may influence patients’ decision making. 
A 3- day food record was encouraged for participants 
who were living at home at the time of data collection, 
however, as only four food records were completed, these 
were not included in our analysis.
The ‘Perception of Nutrition Survey’ (online supple-
mentary material) and the ‘SemiStructured Interview 
Guide’ were developed for the purposes of this study, 
following a literature review and then further refined by 
the research team. The nutrition survey comprised 26 
Likert scale questions. The interview guide included 16 
open- ended questions targeting: participants’ perception 
of their swallowing and nutrition; their gastrostomy deci-
sion making experience; as well as factors contributing 
to their decision. The guide was piloted with one MND 
patient and one HCP prior to study visits. No changes 
were suggested. Interviews were conducted by one 
researcher who was unknown to the participants and not 
involved in their care. This researcher was trained to use 
the interview guide by three members of the research 
team, during two training sessions prior to commencing 
study visits. Interviews were audio recorded, with member 
checking30 conducted throughout the interview and on 
completion.
sequence
Swallowing, nutrition and interview data were collected 
concurrently, at three separate appointments (30–60 min), 
spanning a 3- week period. This time frame was selected 
as minimal functional change between assessments would 
be expected during this short period; and also to mini-
mise the burden on participants. The order of the assess-
ments varied according to availability of the researchers. 
The appointment location was determined by partici-
pants’ preferences, either: the participant’s home; inpa-
tient unit of the hospital setting or hospital outpatient 
appointment.
Data analysis
Demographic and disease-related data
Given the small sample size of this study, a descriptive 
report of demographic and disease- related characteristics 
is presented, comparing those who accepted gastrostomy 
with those who declined (n=33).
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Table 2 Demographic and disease- related characteristics 
for those who accepted gastrostomy versus declined 
gastrostomy (n=33)
Characteristic
Accepted
(n=24)
Declined
(n=9)
Mean age (years) 67.6 68.4
Median symptom duration (months) 13 12
Gender
 Female (n=13) 13 0
 Male (n=20) 11 9
Site of onset
 Bulbar (n=14) 12 2
 Limb (n=19) 12 7
Median ‘Rate of Disease 
Progression Score (ie, ∆FS)’ at initial 
visit to the clinic
0.88 2.00
Predicted rate of decline group at 
initial visit to the clinic
 Slow (n=5) 2 3
 Steady (n=16) 16 0
 Rapid (n=12) 6 6
Decision making data
A stepped approach was used to gain a comprehensive 
and cohesive understanding of the reasons why people 
with MND accept or decline gastrostomy:
1. Descriptive analysis of each participants’ physical
function, swallowing ability and nutritional status was 
conducted.
2. Qualitative interviews were transcribed, with removal
of any identifiable content. Transcriptions were then 
imported into QSR NVivo V.11 software (QSR Inter-
national, Melbourne, Australia) for management and 
analysis by one researcher (AH). A stepwise inductive 
approach41 was employed to identify emerging factors 
from the interviews. Participant statements on factors 
influencing their decision making were identified to 
form a framework. These factors were then matched 
against the participants who had identified them and 
grouped into categories. Four researchers reviewed 
the categories, factors and participant statements until 
consensus was reached.
3. Each participants’ quantitative and qualitative datasets
were merged onto the ‘Main Datasheet’ (online sup-
plementary material) for convergent data analysis and 
triangulation.28 29
4. A repeated iteration process was then implemented for
data integration, to increase depth of understanding
of this topic. Four principal investigators collaborated
in three meetings, to first review each participant’s re-
sults; then compare results among all participants, until 
consensus was reached. The MND Service Coordinator
(ie, principal investigator, JL) was present at these
meetings, adding contextualised information on the
MND Service and clinical situation of the participants.
To maintain confidentiality, all participants were
assigned an identification number to represent them in 
the data.
Patient and public involvement.
Patient and public involvement was achieved in the 
following ways. First, during investigators’ (JL and NJ) 
clinical work, informal observations of patients with MND 
engaging in gastrostomy decision making and the chal-
lenges associated with this process, influenced the concep-
tualisation and design of this study. Second, a patient with 
MND trialled the semi- structured interview guide and 
their feedback was incorporated into the design. Finally, 
patient opinion, gathered through stakeholder engage-
ment, also influenced the design and development of this 
study.42
results
Comparing demographic and disease-related characteristics 
for those who accepted gastrostomy versus declined 
gastrostomy
Thirty- three medical discussions regarding gastrostomy 
insertion were held, either as an outpatient (24/33) or 
inpatient (9/33); occurring on average 214 days after 
initial contact with the service (range 0–1365 days). 
Gender ratio included 13 females: 20 males. Mean age at 
the time of gastrostomy discussion was 67.3 years (range 
40–84 years). Site of onset included 19 limb onset and 14 
bulbar onset. Median symptom duration was 13 months 
(range 3–127 months). Median ∆FS was 0.91 (range 
0.07–8.30). Twelve participants were predicted to be 
‘rapid’ decliners (7 males and 5 females); 16 were ‘steady’ 
decliners (9 males, 7 females) and 5 were ‘slow’ decliners 
(4 males, 1 female).34
Following medical discussion, 24/33 (73%) consented 
to gastrostomy referral (figure 1). The median time 
between discussion and referral was 6 days (range 0–57 
days), with nine participants taking >1 week to consent 
to referral; and three of these >1 month. All participants 
who were referred for gastrostomy, underwent percuta-
neous endoscopic gastrostomy (ie, PEG) insertion at 
a later point,6 with a median of 52 days (range 18–163 
days) between referral and insertion. Table 2 compares 
the characteristics of those who accepted gastrostomy 
referral, with those who declined. Age and symptom 
duration appear similar in these two groups, however, 
there appears to be a trend towards females and those 
with bulbar onset accepting gastrostomy. The median 
rate of disease progression score at initial visit to the 
clinic was lower for those who accepted gastrostomy (ie, 
∆FS 0.88 compared with 2.00). In addition, those with a 
predicted ‘steady’ rate of decline appeared more likely to 
accept gastrostomy, when compared with ‘slow’ or ‘rapid’ 
decliners, suggesting that these variables may contribute 
to gastrostomy uptake.
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reasons for accepting or declining gastrostomy
Of the 33 patients who were recommended gastros-
tomy, 16 were excluded from the mixed methods deci-
sion making study for the following reasons: interpreter 
required (n=5); patient unwell or in another hospital 
(n=4); impaired cognition (n=3); inefficient communi-
cation method (n=2) and residing >1 hour’s drive away 
(n=2). One patient was not invited to participate due to 
significant patient and carer stress at the time. Sixteen 
eligible patients were invited to participate in the mixed- 
methods study, of whom 10 provided informed consent 
(figure 1).
There was an average of 32 days between medical 
discussion of gastrostomy and enrolment in the deci-
sion making study (range 6–73 days). Data collection 
was completed between 2 and 31 days post enrolment 
date, with an average of 16 days to complete the three 
appointments. All scored ≥25/30 on the Mini- ACE cogni-
tive screen. Eight participants communicated by speech 
during the interview and one via writing. Sadly, one partic-
ipant died 7 days after enrolment, prior to completing 
data collection.
At the time of data collection, all participants had 
received gastrostomy education from the multidisci-
plinary MND team. Five out of nine had received health 
literature about gastrostomy. Four had prior exposure to 
somebody with a gastrostomy and five had been shown 
a PEG device. Most discussed their decision with family 
(8/10); however, two participants (P3 and P8), instead 
made an autonomous decision.
A summary of participant characteristics for the deci-
sion making study (n=10) are outlined in table 3. Merged 
quantitative and qualitative data can be found on the Main 
Datasheet (online supplementary material). Following a 
repeated iteration process of data analysis and integra-
tion, participant findings were grouped into those who 
‘declined gastrostomy’ or ‘accepted gastrostomy’. These 
results are presented as case vignettes for two reasons. 
First, this allowed illustration of the commonalities and 
differences between the members of each group. Second, 
case vignettes facilitated direct comparison between 
quantitative results and qualitative findings.
Participants who declined gastrostomy
Two of 10 participants initially declined gastrostomy and 
maintained this decision (P2 and P10). These participants 
shared similar characteristics, including: male, limb- 
onset, disease duration <1 year, predicted ‘rapid’ decline 
and >3 kg weight loss. They did, however, differ in their 
swallowing ability. P2 experienced dysphagia, requiring 
modified diet and fluids; whereas P10 showed no signs 
of dysphagia and managed a normal diet. Unfortunately, 
P2 died prior to interview. P10 was interviewed, giving his 
views on why he declined gastrostomy. P10 explained that 
he did not want any life- prolonging interventions, as he 
associated a high level of disability with a poor quality of 
life. He hoped to reduce the time of his illness, so as not 
to be a burden on his wife.
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… when I really started thinking about what was go-
ing to happen and what the benefits, and pros and 
cons were, as to what I would get out of it, I didn’t 
think it was worth it all……all it’s going to do is may-
be give me an extra month or something like that in 
life, in quality that I don’t want and make it uncom-
fortable now.
Knowing what the end result is going to be, the things 
leading up to the end results, and trying to minimise 
the time for that to happen—to be in that state. I’d 
rather accelerate that state (as declining the PEG 
would lead to potentially faster deterioration) than 
be in that state for a few months.
P10 also wanted to be comfortable at the end- of- life and 
remain at home, rather than spending time in hospital to 
undergo gastrostomy surgery.
Yeah, plus too another—plus a hospital stay, like, I 
haven’t got that long anyway, I don’t want to spend 
time in hospital if I don’t need to.
P10 died 10 weeks after the initial gastrostomy discus-
sion was held.
Participants who accepted gastrostomy
The remaining eight participants chose to proceed with 
gastrostomy insertion. Two had their PEG inserted prior 
to enrolment (3 and 16 days prior); the remaining six 
after study enrolment.
Two of eight made their decision immediately following 
medical discussion (P1 and P3). P1 was malnourished, 
but swallowing was normal. He was concerned about his 
nutrition and potential future decline in his swallowing; 
however, his primary reason for gastrostomy was to reduce 
the burden to his wife:
I had to think about my wife because she’s the one 
that’s gotta do things for me. She’s involved as much 
as I am.
P3 had early swallowing difficulties with some choking 
incidents. She ate a mostly normal diet consistency, but 
avoided certain foods due to dysphagia and found it 
harder to swallow medications. P3 was cautious whilst 
eating and drinking, subsequently taking longer to 
complete meals. She feared pneumonia, and there was 
risk of malnourishment with reduced appetite. Neverthe-
less, her weight and oral intake were stable. P3 had prior 
experience of someone with MND who used gastros-
tomy feeding and gave several reasons for immediately 
accepting gastrostomy:
The biggest impact would be being active, remaining 
active and being what they call matriarchal. I know 
that (PEG) is going to give me better quality of life…I 
will be able to stay stronger…it will make me be more 
independent and when I get swallowing less, I can use 
PEG to keep up my nutrition. I am thinking that it 
will help me because you can still go out….I like to go 
shopping with my daughter.
The remaining six participants (ie, P4, P5, P6, P7, 
P8, P9) all experienced decisional conflict—initially 
declining gastrostomy, but later changing their mind. 
Three of these six participants (ie, P5, P7 and P9) were 
observed to have dysphagia or nutritional compromise on 
the clinician- reported measures. These participants also 
reported stress and burden associated with swallowing or 
nutrition in the interview; yet they experienced decisional 
conflict and delay in making their decision for PEG. This 
highlights that changes in a person’s swallowing or nutri-
tion do not necessarily equate with a quick acceptance of 
gastrostomy. P5 had normal swallowing, but his intake was 
moderately reduced due to a loss of appetite and taking 
longer to eat. He experienced less enjoyment of eating, 
requiring encouragement from his family to maintain 
his intake. He ate two meals and drank less than 3 cups 
of fluid each day. P5 thought he only occasionally ate 
enough; but was not overly concerned about this.
P5: I’ll be honest, as regards to PEG, I was very un-
decided. I’ve got a strange outlook on this, but as 
I’ve said to a few people, “I just wish it’d all end” … I 
feel as I’m becoming a burden to everyone. But after 
talking to (MND NSW worker) … and telling me that 
it’s all about quality of life … and sitting down and 
thinking about it, I decided to go ahead with it. But 
I was hesitant even right up until having it done. I 
was unsure but I’m not sorry now… the protein that 
they’ve been pouring into me here, it all—well, so 
much easier because I hate this stuff. I hate pouring 
it down my throat.
P7 had stable weight with no change in intake. She 
managed a normal diet, but avoided certain foods due 
to dysphagia and took longer to eat. P7 had also experi-
enced some choking incidents, so was sometimes fearful 
of eating and drinking. She felt her swallowing problem 
was a major distraction in her life and was often frus-
trated by it, as it made socialising more difficult. P9 also 
had dysphagia, requiring modified food textures. Due 
to some choking incidents, P9 was cautious with eating 
and drinking, consequently taking longer to finish meals. 
Like P7, dysphagia was sometimes a cause of frustra-
tion and made socialising challenging. Each day, P9 ate 
three meals and drank only 3–5 cups of fluid. Despite 
risk of malnourishment, reduced appetite and intake, 
her weight was stable. P9 was not particularly concerned 
about increasing her intake, feeling it was mostly enough.
P9: It was a gradual change in my decision. As swallow-
ing got worse I couldn’t drink water and thickened 
stuff was not pleasant. So I thought to be hydrated in 
summer was a good idea and also taking medications 
would be easier through the tube. When my breath-
ing started deteriorating and I heard that if we left it 
too long I might not be able to have the operation, I 
wanted to get on with it as quickly as possible.
P4 differed (from P5, P7 and P9) in that although her 
nutrition was compromised, it was not causing stress or 
7Labra J, et al. BMJ Open 2020;10:e034751. doi:10.1136/bmjopen-2019-034751
Open access
Table 4 Factors contributing to gastrostomy decision making, identified in the semistructured interviews (n=9)
Contributing factor
Participant number
(A=accepted gastrostomy; D=declined gastrostomy)
1
A
3
A
4
A
5
A
6
A
7
A
8
A
9
A
10
D
Improve/maintain healthy body, nutrition and hydration ✓ ✓ ✓ ✓ ✓ ✓
Reduce carer burden ✓ ✓ ✓ ✓ ✓
Reduce stress of eating and drinking and/or taking medications ✓ ✓ ✓ ✓
Quality of life ✓ ✓ ✓ ✓
Address future nutrition and weight problems ✓ ✓ ✓ ✓
Address future swallowing problems ✓ ✓ ✓
Independence ✓ ✓ ✓
Better of 2 bad choices. Gastrostomy won’t make a difference ✓ ✓ ✓
Participate in family and social activities ✓ ✓
Keep eating as long as possible ✓ ✓
Be comfortable at end of life ✓ ✓
Hope to increase energy ✓
Prevent choking ✓
The value of extending survival ✓
Gain some control ✓
Not spending time in hospital ✓
Reduce time of illness ✓
burden at the current time. P4 had heard of PEG a few 
months prior to study enrolment, but at that time she 
had no bulbar involvement, her appetite was good and 
her weight was stable. At the time of gastrostomy recom-
mendation, P4 did not have dysphagia, however, there 
was significant respiratory impairment. Constipation and 
breathlessness were having a negative impact on her nutri-
tion. P4’s appetite had reduced in the months prior and 
there was little enjoyment associated with eating; however, 
she felt she mostly ate enough for her needs. Sensing that 
her nutrition was likely to continue worsening, P4 even-
tually decided to accept gastrostomy. Nevertheless, her 
only reported reason for accepting gastrostomy was to 
proactively address problems associated with potentially 
worsening swallowing and nutrition in the future, not to 
address her current nutritional issues.
Interestingly, P8’s primary reason for accepting gastros-
tomy was also to address future issues, but only issues 
with nutrition, not swallowing. P8 was the only partici-
pant with normal nutrition and normal swallowing at the 
time of data collection. Nonetheless, he did have signifi-
cant respiratory impairment, so gastrostomy was recom-
mended to ensure he was well enough to undergo the 
procedure.
While other participants focused on quality of life, P6 
was the only participant accepting gastrostomy to make 
a comment regarding the potential of gastrostomy to 
increase survival:
P6: The idea of extending—having a surgical proce-
dure is probably a bit intrusive but it happens, but [I] 
just wonder about the practicality of it—is it worth 
having done to extend your life for 10 weeks?
Although there were no signs of dysphagia on his swal-
lowing assessment (ie, Mann Assessment of Swallowing 
Ability), P6 was fearful of choking. Body mass index 
was ‘normal’, however, P6 had lost 17 kg since symptom 
onset. He reported little interest in eating and meals took 
longer to finish, however, P6 felt he mostly ate enough 
for his needs.
A summary of factors contributing to gastrostomy deci-
sion making, identified in the semi structured interviews 
(n=9) are provided in table 4.
Overall, these results highlight that gastrostomy deci-
sion making in MND is a heterogeneous process, varying 
from person to person; and irrespective of the presence 
of swallowing impairment or nutritional compromise. In 
addition, there may be disparity between patient percep-
tions’ of their swallowing or nutrition and clinician- 
reported measures.
DIsCussIOn
Gastrostomy uptake and decision making is a compli-
cated, multifaceted process for people living with MND. 
This prospective study is the first of its kind, utilising 
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a convergent mixed- methods approach28 to explore 
demographic and disease- related factors contributing to 
gastrostomy uptake in MND; and the reasons why patients 
accept or decline gastrostomy. Results provide further 
insights to: empower HCPs; better inform larger- scale 
studies, clinical guidelines and development of shared 
decision making aids; and finally, to improve the decision 
making experience for people living with MND.
Integration of quantitative and qualitative data suggests 
a heterogeneous decision making process for people 
living with MND, irrespective of the presence of swal-
lowing impairment or nutritional compromise. At times 
there may also be some disparity between patient percep-
tions’ of their swallowing or nutrition and results from 
clinician- reported measures; an important consideration 
for clinicians when approaching gastrostomy discussions. 
While patient perceptions of swallowing and nutrition do 
contribute to gastrostomy acceptance,26 these factors may 
not be the sole or primary reasons for accepting gastros-
tomy. Other reasons such as reducing carer burden,24 
improving QoL,24 increasing independence, continuing 
participation in social outings and gaining control24 were 
reported. Reasons for declining gastrostomy focused on 
avoiding life- prolonging measures to limit carer burden, 
as well as avoiding hospital admission for the procedure. 
The gastrostomy uptake rate in our study was higher 
than previously reported rates from an Australian MND 
clinic- based study,16 yet similar to the rate reported by 
Greenaway et al.24 This is the first study to highlight rate 
of disease progression as a potential variable contributing 
to gastrostomy uptake. All participants with a predicted 
‘steady’ rate of decline accepted gastrostomy, whereas 
those with predicted ‘slow’ or ‘rapid’ decline appeared 
less likely to accept. Gender may also contribute to 
gastrostomy uptake, with women appearing more likely 
to accept gastrostomy than men, this being similar to 
previous findings.43 Differences in site of onset were also 
observed; however, age and symptom duration appeared 
similar among both groups.
The timing of the decision varied according to patients’ 
priorities and concerns. While most patients eventually 
consented to gastrostomy referral, this decision could 
take an extended period of time,26 regardless of the pres-
ence of swallowing impairment or nutritional compro-
mise. The median time between medical discussion and 
gastrostomy referral in our study was <1 week. Even so, 
this gap was >1 month in almost 10% of the cohort, with 
the longest taking 57 days. Additionally, there were delays 
between referral and gastrostomy insertion. These find-
ings help to quantify the decision making and referral 
periods, highlighting a combination of decisional conflict 
for some patients, as well as lengthy hospital waiting times 
to undergo the procedure at this site. With this in mind, 
early gastrostomy discussions that are: person- centred, 
exploratory, regularly reviewed post initial introduction, 
and allow for the fact that patients may take days, weeks 
or months to consider their decision; may improve the 
patient’s decision making experience and their health 
outcomes. Decision making models and aids that support 
proactive interdisciplinary and participative approaches 
to care discussions, may be helpful in these circum-
stances, to promote informed decisions that are consis-
tent with personal values and beliefs.18 42 44 45 These results 
also highlight important considerations for gastrostomy 
services, when aiming for a more responsive service 
delivery model, enabling rapid access to insertion.
While gastrostomy decision making has been explored 
in other conditions44 46 47 and in conjunction with NIV 
decision making in MND,4 18 24 few studies have focused 
solely on gastrostomy decision making in MND,26 48 and 
none have used a mixed- methods approach for compre-
hensive understanding of this complex topic. Larger- 
scale, mixed- methods comparisons across a variety of sites 
would assist with identifying how different clinical models 
or decision making aids might impact on gastrostomy 
uptake and decision making. Additionally, future studies 
investigating how clinicians decide patients’ suitability 
for gastrostomy, and the frequency of reviewing patients’ 
decisions would add new insights.
This study was limited by the small sample size and use of 
a single site, thus incorporating selection bias and limiting 
generalisation of findings. The first author (JL) acted as 
both clinician and researcher in this study. The advan-
tage of this participant observer role was added famil-
iarity with the study population and clinical processes,49 
however, this relationship may have introduced observer 
bias, as this clinician was also involved in data collection 
and analysis. To minimise this bias in the data collection 
phase, an independent researcher was used to conduct 
the interviews. The interviews included only one person 
who declined gastrostomy, reflecting the uptake rate in 
this study and the proportion of decliners included in 
previous studies.16 24 Even so, further research exploring 
the reasons for declining gastrostomy is required. Due to 
small sample size and the nature of this study, we were 
unable to perform statistical analyses and draw strong 
conclusions from the data. Nevertheless, the results 
provide important foundational considerations for future 
larger- scale studies. Future longitudinal studies inves-
tigating the relationship between gastrostomy uptake 
and: demographic, disease- related factors, swallowing, 
nutrition and respiratory markers would allow for more 
detailed comparisons; and better inform clinicians about 
the timing of gastrostomy recommendation.
COnClusIOn
The Australian healthcare system may be unable to facil-
itate well- timed gastrostomy insertion. Future research 
may give greater insight into how healthcare organisations 
can better facilitate gastrostomy decision making, as well 
as rapid access to insertion, in order to meet the needs 
of people living with MND. Larger, prospective, multisite 
studies that provide further insights into both quantita-
tive and qualitative reasons for gastrostomy acceptance 
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and decline are required, to better inform clinical guide-
lines and minimise the impacts of delayed insertion.
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